| Autor: |
Roylance, Peter J., Adornato, Frank A., Currie, William J. C., Taglieber, Ulrich |
| Zdroj: |
Drug Information Journal; October 1996, Vol. 30 Issue: 4 p869-873, 5p |
| Abstrakt: |
Criticism has been expressed from time to time that United States pharmaceutical companies present different prescribing information to physicians in developing countries from that approved and published in the United States. This article discusses some of the factors which may lead to different statements in national labels. It also provides an outlook on trends toward harmonization in the European Union. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
